NCT06443190 Wichitasowin: Indigenous Patient Navigator for Young Adults Study
| NCT ID | NCT06443190 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Chronic Diseases in Adolescence |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-09-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this pathway is to establish and evaluate a novel Indigenous-led patient navigator (IPN) program for Indigenous adolescents living with chronic health conditions in Maskwacis, Alberta. Over the last three years a community-based participatory research partnership was developed with Elders and community members from Maskwacis, Maskwacis Health Services, and researchers from the University of Alberta. Previous research identified the need for an IPN to support Indigenous young adults and their caregivers in managing their health conditions transitioning into adulthood and transferring from pediatric to adult healthcare. The aim of partnership now is to evaluate whether a community-derived IPN program co-designed with an established group of Maskwacis Elders, Knowledge Keepers, healthcare providers, caregivers and youth with lived experience can aid in improving the experience of transitioning into adult healthcare services for Indigenous youth and their families living in Maskwacis, Alberta.
Eligibility Criteria
Inclusion Criteria: * age 16-25 years; * having chronic health condition of at least 3 months' duration that requires adult specialty follow-up care, including physical conditions (e.g., diabetes), mental health conditions (e.g., anxiety, depression), and/or developmental disorders (e.g., autism, fetal alcohol spectrum disorder); * residing in Maskwacis or from the communities of Maskwacis but currently residing elsewhere; * self-identified as an Indigenous person; * reading level ≥ grade 6. For participants with developmental or intellectual delay (\< grade 6 reading level), they may take part in the program alongside their caregiver(s). Exclusion Criteria: * not identifying as Indigenous * not residing in Maskwacis
Frequently Asked Questions
Who can join the NCT06443190 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 25 Years, studying Chronic Diseases in Adolescence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06443190 currently recruiting?
Yes, NCT06443190 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Alberta to inquire about joining.
Where is the NCT06443190 trial being conducted?
This trial is being conducted at Edmonton, Canada.
Who is sponsoring the NCT06443190 clinical trial?
NCT06443190 is sponsored by University of Alberta. The trial plans to enroll 20 participants.